Neuroinflammatory mechanisms of post-traumatic epilepsy.

Sanjib Mukherjee, Gabriel M Arisi, Kaley Mims, Gabriela Hollingsworth, Katherine O'Neil, Lee A Shapiro
Author Information
  1. Sanjib Mukherjee: Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA.
  2. Gabriel M Arisi: Department of Physiology, Federal University of Sao Paulo - Escola Paulista de Medicina, Sao Paulo, Brazil. arisi@unifesp.br.
  3. Kaley Mims: Texas A&M University, College Station, TX, USA.
  4. Gabriela Hollingsworth: Texas A&M University, College Station, TX, USA.
  5. Katherine O'Neil: Texas A&M University, College Station, TX, USA.
  6. Lee A Shapiro: Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA. lshapiro@medicine.tamhsc.edu. ORCID

Abstract

BACKGROUND: Traumatic brain Injury (TBI) occurs in as many as 64-74 million people worldwide each year and often results in one or more post-traumatic syndromes, including depression, cognitive, emotional, and behavioral deficits. TBI can also increase seizure susceptibility, as well as increase the incidence of epilepsy, a phenomenon known as post-traumatic epilepsy (PTE). Injury type and severity appear to partially predict PTE susceptibility. However, a complete mechanistic understanding of risk factors for PTE is incomplete.
MAIN BODY: From the earliest days of modern neuroscience, to the present day, accumulating evidence supports a significant role for neuroinflammation in the post-traumatic epileptogenic progression. Notably, substantial evidence indicates a role for astrocytes, microglia, chemokines, and cytokines in PTE progression. Although each of these mechanistic components is discussed in separate sections, it is highly likely that it is the totality of cellular and Neuroinflammatory interactions that ultimately contribute to the epileptogenic progression following TBI.
CONCLUSION: This comprehensive review focuses on the Neuroinflammatory milieu and explores putative mechanisms involved in the epileptogenic progression from TBI to increased seizure-susceptibility and the development of PTE.

Keywords

References

  1. Nat Med. 2010 Apr;16(4):413-9 [PMID: 20348922]
  2. J Neurotrauma. 2009 Aug;26(8):1315-24 [PMID: 19317601]
  3. Epilepsy Curr. 2019 Jul-Aug;19(4):261-263 [PMID: 31208231]
  4. eNeuro. 2015 Sep 28;2(5): [PMID: 26478908]
  5. Trends Neurosci. 2008 Dec;31(12):653-9 [PMID: 18945498]
  6. J Neurotrauma. 2018 Feb 15;35(4):639-651 [PMID: 29149810]
  7. Neurosci Lett. 2010 Dec 17;486(3):197-201 [PMID: 20869426]
  8. J Neuroinflammation. 2016 May 24;13(1):117 [PMID: 27220367]
  9. J Neurotrauma. 2006 Oct;23(10):1518-28 [PMID: 17020486]
  10. N Engl J Med. 1998 Jan 1;338(1):20-4 [PMID: 9414327]
  11. Acta Neuropathol. 2019 May;137(5):731-755 [PMID: 30535946]
  12. Front Neurosci. 2019 Jan 09;12:1014 [PMID: 30686980]
  13. Trends Neurosci. 2013 Mar;36(3):174-84 [PMID: 23298414]
  14. J Neuroinflammation. 2009 Dec 24;6:40 [PMID: 20034406]
  15. J Comp Neurol. 2000 Dec 11;428(2):240-53 [PMID: 11064364]
  16. J Neurosci Res. 2003 Jul 15;73(2):176-87 [PMID: 12836160]
  17. Epilepsy Res. 2006 Apr;69(1):53-66 [PMID: 16480853]
  18. Epilepsy Curr. 2006 Jan-Feb;6(1):1-5 [PMID: 16477313]
  19. Brain Plast. 2018 Aug 10;3(2):169-181 [PMID: 30151341]
  20. Epilepsia. 1976 Jun;17(2):207-15 [PMID: 820549]
  21. Eur J Neurosci. 2000 Jun;12(6):2087-96 [PMID: 10886348]
  22. Epilepsy Curr. 2019 Sep;19(5):316-320 [PMID: 31409149]
  23. Brain Inj. 2007 Feb;21(2):201-14 [PMID: 17364531]
  24. Neurochem Res. 2018 Oct;43(10):1978-1985 [PMID: 30173323]
  25. Injury. 2007 Dec;38(12):1392-400 [PMID: 18048036]
  26. Neurology. 1985 Oct;35(10):1406-14 [PMID: 3929158]
  27. Sci Rep. 2017 Jan 20;7:40112 [PMID: 28106051]
  28. Adv Neurol. 1975;8:1-9 [PMID: 804229]
  29. Brain. 2015 May;138(Pt 5):1208-22 [PMID: 25765328]
  30. Nat Neurosci. 2007 Dec;10(12):1544-53 [PMID: 18026096]
  31. Epilepsia. 2012 Jun;53 Suppl 1:98-108 [PMID: 22612814]
  32. Toxicol Appl Pharmacol. 2020 May 15;395:114980 [PMID: 32234516]
  33. Epilepsia. 2003;44(s10):21-6 [PMID: 14511391]
  34. Brain Behav Immun. 2016 Nov;58:291-309 [PMID: 27477920]
  35. Brain Behav Immun. 2017 Jul;63:197-209 [PMID: 27818218]
  36. J Cereb Blood Flow Metab. 2016 Aug;36(8):1434-48 [PMID: 26661249]
  37. Nature. 2017 Jan 26;541(7638):481-487 [PMID: 28099414]
  38. N Engl J Med. 1990 Aug 23;323(8):497-502 [PMID: 2115976]
  39. J Neurochem. 2004 Jul;90(1):89-101 [PMID: 15198670]
  40. J Neuroinflammation. 2019 Mar 28;16(1):66 [PMID: 30922332]
  41. Int J Mol Sci. 2017 Dec 01;18(12): [PMID: 29194369]
  42. Glia. 2018 Dec;66(12):2719-2736 [PMID: 30378170]
  43. Z Laryngol Rhinol Otol. 1971 Feb;50(2):140-5 [PMID: 5542591]
  44. J Cereb Blood Flow Metab. 2011 Feb;31(2):658-70 [PMID: 20717122]
  45. J Neurosci. 2017 Aug 16;37(33):7864-7877 [PMID: 28724747]
  46. J Neurosci. 2009 Jul 15;29(28):8927-35 [PMID: 19605630]
  47. J Neurol. 2009 May;256(5):796-802 [PMID: 19252806]
  48. Front Cell Neurosci. 2014 Oct 21;8:306 [PMID: 25374505]
  49. Epilepsia. 2008;49 Suppl 2:33-41 [PMID: 18226170]
  50. Ann Neurol. 2014 Jun;75(6):864-75 [PMID: 24659129]
  51. J Neurosurg. 2018 Apr 27;130(4):1080-1097 [PMID: 29701556]
  52. Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6179-84 [PMID: 18375756]
  53. Glia. 2018 Aug;66(8):1788-1804 [PMID: 29683209]
  54. J Neurosci Res. 2011 Jul;89(7):986-1000 [PMID: 21488090]
  55. Brain Res Brain Res Rev. 2005 Feb;48(1):43-56 [PMID: 15708627]
  56. J Neurosurg. 1962 Feb;19:122-9 [PMID: 13877492]
  57. J Neuroinflammation. 2005 Oct 31;2:24 [PMID: 16259628]
  58. Epilepsia. 2007 Sep;48(9):1785-1800 [PMID: 17521344]
  59. J Neurosci. 2001 Nov 1;21(21):8523-37 [PMID: 11606641]
  60. Neuropharmacology. 2013 Jun;69:16-24 [PMID: 22521336]
  61. Ann Neurol. 2011 Sep;70(3):374-83 [PMID: 21710619]
  62. Exp Neurol. 2017 Apr;290:85-94 [PMID: 28081963]
  63. Brain Res Rev. 2007 Oct;55(2):390-4 [PMID: 17239443]
  64. Neuroscience. 2005;136(3):823-31 [PMID: 16344154]
  65. Front Mol Neurosci. 2011 Sep 16;4:21 [PMID: 21954376]
  66. Exp Neurol. 2014 Nov;261:156-62 [PMID: 24861442]
  67. Acta Neuropathol. 2000 Sep;100(3):313-22 [PMID: 10965802]
  68. J Neurotrauma. 2004 Nov;21(11):1553-61 [PMID: 15684648]
  69. Epilepsia. 2003;44(s10):11-7 [PMID: 14511389]
  70. Oncotarget. 2018 Jun 1;9(42):26954-26976 [PMID: 29928494]
  71. J Neuroinflammation. 2014 Jun 03;11:98 [PMID: 24889886]
  72. Cold Spring Harb Perspect Biol. 2015 Jul 01;7(8):a020537 [PMID: 26134003]
  73. Neuroreport. 2004 Feb 9;15(2):259-62 [PMID: 15076748]
  74. J Neurosci. 2009 Mar 11;29(10):3276-87 [PMID: 19279265]
  75. J Leukoc Biol. 2013 Jun;93(6):865-73 [PMID: 23446148]
  76. Brain Res. 2018 Feb 15;1681:52-63 [PMID: 29274879]
  77. Adv Exp Med Biol. 2019;1175:149-179 [PMID: 31583588]
  78. Epilepsy Res. 2015 Nov;117:104-16 [PMID: 26432760]
  79. Neurol Res. 2016 Mar;38(3):269-74 [PMID: 26315855]
  80. J Neurotrauma. 2003 Jan;20(1):87-103 [PMID: 12614591]
  81. Neuroscience. 2003;121(4):1017-29 [PMID: 14580952]
  82. Neurosci Lett. 2004 Jul 22;365(2):106-10 [PMID: 15245788]
  83. Epilepsia. 2006 Aug;47(8):1373-82 [PMID: 16922884]
  84. Exp Neurol. 2016 Jan;275 Pt 3:316-327 [PMID: 26342753]
  85. Int J Legal Med. 2018 Mar;132(2):531-539 [PMID: 29306988]
  86. Epilepsia. 1970 Mar;11(1):81-94 [PMID: 4987163]
  87. Front Neurol. 2013 Mar 21;4:28 [PMID: 23519723]
  88. Front Cell Neurosci. 2013 Apr 17;7:45 [PMID: 23616747]
  89. Ital J Pediatr. 2016 Mar 09;42:31 [PMID: 26960986]
  90. Cell Mol Neurobiol. 2020 Oct;40(7):1199-1211 [PMID: 32060858]
  91. J Neuropathol Exp Neurol. 2014 Jan;73(1):14-29 [PMID: 24335533]
  92. Acta Neuropathol. 2002 Jun;103(6):541-9 [PMID: 12012085]
  93. Epilepsy Res. 2018 Oct;146:41-49 [PMID: 30071385]
  94. PLoS One. 2019 Apr 3;14(4):e0214741 [PMID: 30943276]
  95. Exp Neurol. 2017 Nov;297:62-72 [PMID: 28756201]
  96. Glia. 2006 Dec;54(8):815-25 [PMID: 16977605]
  97. Brain Res. 2005 Apr 8;1040(1-2):81-91 [PMID: 15804429]
  98. Mol Psychiatry. 1997 Mar;2(2):133-6 [PMID: 9106236]
  99. Acta Neuropathol. 1999 Oct;98(4):396-406 [PMID: 10502046]
  100. J Neurosci. 2007 Oct 3;27(40):10674-84 [PMID: 17913901]
  101. Epilepsia. 1993 May-Jun;34(3):453-68 [PMID: 8504780]
  102. J Neurotrauma. 2021 Apr 15;38(8):1193-1201 [PMID: 21939392]
  103. Neural Plast. 2016;2016:1347987 [PMID: 27274873]
  104. Behav Brain Res. 2015 Sep 15;291:315-324 [PMID: 26031379]
  105. Shock. 1995 Nov;4(5):311-7 [PMID: 8595516]
  106. Front Neurosci. 2011 Mar 30;5:45 [PMID: 21490706]
  107. Brain. 2011 Aug;134(Pt 8):2248-60 [PMID: 21764818]
  108. Clin Neurol Neurosurg. 2006 Jul;108(5):433-9 [PMID: 16225987]
  109. J Neurosci. 2017 Oct 25;37(43):10278-10289 [PMID: 28924012]
  110. J Clin Lab Anal. 2010;24(3):154-9 [PMID: 20486195]
  111. Epilepsia. 2016 Feb;57(2):e45-50 [PMID: 26666401]
  112. Neurobiol Dis. 2019 Mar;123:20-26 [PMID: 30030025]
  113. Brain Struct Funct. 2017 Apr;222(3):1543-1556 [PMID: 27586142]
  114. Neuron. 2014 Feb 19;81(4):728-39 [PMID: 24559669]
  115. J Neurol Neurosurg Psychiatry. 1952 May;15(2):93-8 [PMID: 14928078]
  116. Neurobiol Dis. 2015 Jun;78:115-25 [PMID: 25836421]
  117. Cell Transplant. 2017 Jul;26(7):1314-1318 [PMID: 28933222]
  118. Brain Res. 2007 May 29;1149:30-7 [PMID: 16904657]
  119. Epilepsy Res. 2006 Oct;71(2-3):107-16 [PMID: 16806825]
  120. Neuroimmunomodulation. 2000;7(3):153-9 [PMID: 10754403]
  121. Seizure. 2015 Feb;25:136-40 [PMID: 25455727]
  122. Br J Pharmacol. 2016 Feb;173(4):692-702 [PMID: 25752446]
  123. Brain Behav Immun. 2017 Oct;65:90-94 [PMID: 28232173]
  124. J Neurosci Res. 2007 Aug 1;85(10):2120-5 [PMID: 17510981]
  125. Brain Behav Immun. 2015 Mar;45:253-62 [PMID: 25555531]
  126. Neuroreport. 1996 Sep 2;7(13):2181-5 [PMID: 8930985]
  127. Neuroscience. 2020 Sep 1;443:188-205 [PMID: 31982472]
  128. Neurobiol Dis. 2019 Mar;123:115-121 [PMID: 29859872]
  129. Eur J Neurosci. 2007 Aug;26(3):583-92 [PMID: 17686039]
  130. Cold Spring Harb Perspect Biol. 2015 Feb 13;7(12): [PMID: 25680832]
  131. J Neuroinflammation. 2015 Jul 02;12:129 [PMID: 26133170]
  132. Annu Rev Physiol. 2010;72:335-55 [PMID: 20148679]
  133. Ugeskr Laeger. 1992 Jan 20;154(4):215-6 [PMID: 1736453]
  134. Cell Rep. 2019 Sep 10;28(11):2923-2938.e8 [PMID: 31509752]
  135. Exp Neurol. 2014 Aug;258:5-16 [PMID: 25017883]
  136. J Neuroimmunol. 2015 Dec 15;289:143-51 [PMID: 26616884]
  137. PLoS One. 2013 May 14;8(5):e64078 [PMID: 23691153]
  138. J Neurosci Res. 2013 Feb;91(2):230-9 [PMID: 23172820]
  139. J Neuroimmune Pharmacol. 2013 Jun;8(3):494-509 [PMID: 23354784]
  140. Science. 2005 May 27;308(5726):1314-8 [PMID: 15831717]
  141. Prog Brain Res. 2007;163:155-66 [PMID: 17765717]
  142. J Neurol Sci. 2014 Jul 15;342(1-2):25-8 [PMID: 24834995]
  143. Epilepsia. 2018 Jan;59(1):37-66 [PMID: 29247482]
  144. Neuron. 2012 May 24;74(4):691-705 [PMID: 22632727]
  145. Int Rev Neurobiol. 2007;82:247-63 [PMID: 17678965]
  146. Epilepsia. 2000;41 Suppl 6:S181-4 [PMID: 10999541]
  147. PLoS One. 2016 Jan 25;11(1):e0148001 [PMID: 26808663]
  148. J Neuroinflammation. 2017 Jan 13;14(1):10 [PMID: 28086980]
  149. J Neuroinflammation. 2008 Jun 30;5:28 [PMID: 18590543]
  150. J Clin Neurosci. 2015 Apr;22(4):627-31 [PMID: 25542591]
  151. Epilepsia. 2008 Jun;49 Suppl 5:13-8 [PMID: 18522596]

Grants

  1. R01 NS104282/NINDS NIH HHS

MeSH Term

Brain Injuries, Traumatic
Cytokines
Epilepsy
Humans
Inflammation
Microglia

Chemicals

Cytokines

Word Cloud

Created with Highcharts 10.0.0TBIPTEpost-traumaticprogressionepilepsyepileptogenicTraumaticbraininjuryincreasesusceptibilitymechanisticevidenceroleneuroinflammatorymechanismsBACKGROUND:occursmany64-74millionpeopleworldwideyearoftenresultsonesyndromesincludingdepressioncognitiveemotionalbehavioraldeficitscanalsoseizurewellincidencephenomenonknownInjurytypeseverityappearpartiallypredictHowevercompleteunderstandingriskfactorsincompleteMAINBODY:earliestdaysmodernneurosciencepresentdayaccumulatingsupportssignificantneuroinflammationNotablysubstantialindicatesastrocytesmicrogliachemokinescytokinesAlthoughcomponentsdiscussedseparatesectionshighlylikelytotalitycellularinteractionsultimatelycontributefollowingCONCLUSION:comprehensivereviewfocusesmilieuexploresputativeinvolvedincreasedseizure-susceptibilitydevelopmentNeuroinflammatoryAstrocytesChemokinesCytokinesEpileptogenesisInflammationMicroglia

Similar Articles

Cited By (38)